Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.328 EUR | -1.80% | +0.61% | -18.20% |
Mar. 11 | Biofrontera Files Prospectus for Potential Secondary Stock Offerings | MT |
Mar. 05 | Medicus Pharma Names COO | MT |
Sales 2021 | 28.79M 30.88M | Sales 2022 | 25.74M 27.61M | Capitalization | 97.31M 104M |
---|---|---|---|---|---|
Net income 2021 | 38M 40.76M | Net income 2022 | -44M -47.19M | EV / Sales 2021 | 2.79 x |
Net cash position 2021 | 3.61M 3.87M | Net cash position 2022 | 4.88M 5.23M | EV / Sales 2022 | 3.59 x |
P/E ratio 2021 |
2.18
x | P/E ratio 2022 |
-1.98
x | Employees | 92 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 32.4% |
Latest transcript on Biofrontera AG
1 day | -1.80% | ||
1 week | +0.61% | ||
Current month | -4.09% | ||
1 month | -4.09% | ||
3 months | -29.91% | ||
6 months | -40.36% | ||
Current year | -18.20% |
Managers | Title | Age | Since |
---|---|---|---|
Director of Finance/CFO | 55 | 22-09-11 | |
Anke zur Muehlen
IRO | Public Communications Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 63 | 21-12-13 | |
Director/Board Member | - | 21-12-13 | |
Heikki Lanckriet
BRD | Director/Board Member | 47 | 21-12-13 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 0.328 | -1.80% | 7,000 |
24-04-24 | 0.334 | -3.47% | 11,165 |
24-04-23 | 0.346 | 0.00% | 13,534 |
24-04-22 | 0.346 | +10.90% | 13,534 |
24-04-19 | 0.312 | -4.29% | 57,830 |
Delayed Quote Xetra, April 25, 2024 at 11:36 am EDT
More quotesQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-18.20% | 22.42M | |
+24.17% | 556B | |
-6.33% | 354B | |
+19.90% | 331B | |
+7.95% | 296B | |
+13.45% | 233B | |
+6.04% | 201B | |
-10.51% | 193B | |
-12.26% | 143B | |
-6.47% | 144B |
- Stock Market
- Equities
- B8F Stock